Presentation Transcript
Adverse Drug Reaction :Adverse Drug Reaction Dr. Manjunath
Introduction :Introduction Defn: “an unwanted or harmful reaction experienced following the administration of a drug or combination of drugs under normal conditions of use and suspected to be related to the drug”
Trivial OR Serious Or fatal
Slide 3:Requires
Treatment
in dosing
Discontinuation
Caution in future
Occurrence
immediately or after prolonged use
or after termination
Mild ADRs common, [incidence 10-25%]
with polypharmacy
Acceptability: linked to Therap. Use; Risk Benefit Ratio
: Type A: Response qualitatively normal but quantitatively abnormal
Common, less serious, dose related,
corrected by dose adjustment
include side effect, toxic effect, withdrawal
Type B: Because of patient peculiarities; Eg. Allergy, idiosyncrasy
Dose related; uncommon;
Serious withdrawal of drug required
Not always predictable / preventable
Slide 5:Type “C”
These reactions are associated with long-term drug therapy e.g. Benzodiazepine dependence and Analgesic nephropathy. They are well known and can be anticipated.
Type “D” reactions
These reactions refer to carcinogenic and teratogenic effects. These reactions are delayed in onset
Slide 6:Type E
End of dose effect for example abrupt cessation of corticosteroids produces acute adrenal insufficiency and stoppage of propranolol can produce rebound effect
Type F
Failure of therapy. OCP failure when on antitubercular therapy
Severity of ADR: :Severity of ADR: Minor: no need of therapy, antidote, or hospitalization
Moderate: requires drug change , specific treatment, hospitalization
Severe: Potentially life threatening; permanent damage, and prolonged hospitalization.
Lethal: Directly or indirectly leads to death
Prevention of ADR: :Prevention of ADR: [1] Avoid inappropriate drugs in the context of clinical condition
[2] Use right dose, route, frequency based on patient variables
[3] Elicit medication history; consider untoward incidents
[4] Elicit history of allergies [in patients with allergic diseases]
[5] Rule out drug interactions
[6] Adopt right technique: Eg slow iv injection of aminophylline
[7] Carry out appropriate monitoring [Eg PT with warfarin; Li levels]
Types of ADRs :Types of ADRs [1] Side Effects: unavoidable, predictable, dose amelioration
Occurs as Extension of the same therapeutic effect: Eg.
Atropine as antisecretory in preanesthetic medication dry mouth
Occurs as a distinctly different effect: Eg.
Promethazine as antiallergic sedation
Estrogen as antiovulatory nausea
Side effect exploited for a therapeutic use: Eg
Codeine [antitussive] constipating action used in diarrhoea
Sulfonylureas [tested as antibacterials] were found tobl glucose
Slide 10:[2] Secondary effects: Indirect effect of therapy
Eg. Iintestinal microflora killed by tetracycline superinfection
Corticosteroids immunity oral candidiasis
: [3] Toxic effects: [Overdose or prolonged use]
Atropine delirium ;
Paracetamol hepatic necrosis
Barbiturates coma;
Morphine respiratory failure
Slide 12:EVALUATION
AIRWAY
BREATHING
CIRCULATION
DEGREE OF CONSCIOUSNESS
HISTORY OF EXPOSURE/ INGESTION
PHYSICAL EXAMINATION
DECONTAMINATION
GASTRIC LAVAGE
INDUCTION OF EMESIS
CONTRAINDICATIONS TO EMESIS
ACTIVATED CHARCOAL
OTHER DECONTAMINATION
SUPPORTIVE CARE
RESPIRATORY
CARDIOVASCULAR
CNS
Slide 13:DIAGNOSTIC STUDIES
BLOOD TESTS
ECG
X RAYS
SPECIFIC DRUG LEVELS
ENHANCING ELIMINATION
ACTIVATED CHARCOAL
FORCED ALKALINE DIURESIS
HAEMODIALYSIS/PERFUSION
ANTIDOTES
Organophosphates – atropine, oximes
Morphine – naloxone
Benzodiazepines – flumazenil
Paracetamol – N- acetyl cysteine
Slide 15:[4] Intolerance:
Opposite of tolerance: sensitivity to low doses
few doses of carbamazepine ataxia [ defective movement/gait]
single dose of triflupromazine muscular dystonia
Slide 16:[5] Idiosyncrasy: genetically determined atypical / bizarre effect
Barbiturate excitement & mental confusion
Streptomycin deafness with single dose
Slide 17:[6] Drug allergy: [ or hypersensitivity]
Immunologically mediated
Independent of dose
Occurs in a small proportion;
Prior sensitization required
1-2 weeks required after first dose
Drug acts as an antigen or Hapten
Chemically related drugs may show cross sensitivity
Same drug can cause diff allergic reactions in diff individuals
continued.. :continued.. Type I: urticaria, angioedema, asthma, anaphylactic shock
Type II: Thrombocytopenia, agranulocytosis, aplastic anemia, SLE
Type III: Arthralgia, lymphadenopathy, Steven Johnson Synd.
Type IV: contact dermatitis, fever, photosensitisation
Eg: penicillin, sulfonamides, carbamazepine, methyldopa
[7]Photosensitivity: :[7]Photosensitivity: Phototoxic: Drug accumulates in skin absorbs light photochemical reaction photobiological reaction tissue damage [Eg erythema, edema, blistering etc] Eg tetracyclines
Photoallergic: drug cell mediated immune response contact dermatitis on exposure to light. Eg sulfonamides, griseofulvin etc.
Slide 22:[8]Drug Dependence:
Psychological:
Physical dependence:
Slide 23:[9]Teratogenicity: Drug use in pregnancy affects offspring
Eg Thalidomide phocomelia;
phenytoin cleft palate
Slide 25:[10 ]Carcinogenicity & mutagenicity:
Anticancer drugs, estrogens
Slide 26:[11] Drug induced deseases, Iatrogenic diseases :
Salicylates peptic ulcer;
Phenothiazines parkinsonism;
INH hepatitis
Slide 27:12. Drug withdrawal reaction
Propranolol hypertension
Acute adrenal insufficiency following withdrawal of corticosteroids